Answers are grounded in this paper and cite their sources.
The fluorescence quenching of multiple resonance thermally activated delayed fluorescence (MR-TADF) materials has remained a formidable challenge due to the strong π-π packing and intense intermolecular aggregation. To this end, we have designed MR-TADF molecules modified with adamantane with large spatial hindrance, named BN-Ad, to mitigate the intermolecular π-π stacking be-tween the rigid planar skeletons and prevent aggregation-caused quenching. Photoelectric properties of BN-Ad in solutions and thin films were systematically investigated, and the electroluminescence properties were characterized by fabricating organic light-emitting diode devices (OLEDs). The optimized device employing BN-Ad exhibited a maximum external quantum efficiency (EQEmax) of 32.3% peaking at 500 nm with a small full-width at half-maximum (FWHM) of only 35 nm. When the doping ratio in-creased to 50 wt%, the EQEmax can still be maintained at 11.2% with a slightly red-shifted emission peak at 508 nm and moderately widened FWHM of 53 nm.
No takes yet. Share an insight, caveat, or question.
Qi et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: